Manuscripts
August 10, 2022
Incidence of SARS-CoV-2 and subsequent mortality in a multi-site cohort of patients with cancer in the CancerLinQ Discovery database
JCO Oncology Practice
Ray E et al
June 3, 2022
Retrospective analysis of real-world management of EGFR-mutated advanced NSCLC, after first-line EGFR-TKI treatment: US treatment patterns, attrition, and survival data
Drugs - Real World Outcomes
Nieva J et al
November 17, 2020
Utilizing Data Visualization to Identify Survival and Treatment Differences Between Women With De Novo and Recurrent Metastatic Breast Cancer
Clinical Breast Cancer
Gilbert A et al
March 11, 2021
Identification of transgender people with cancer in electronic health records (EHR): Recommendations based on CancerLinQ observations
JCO Oncology Practice
Alpert AB et al
January 7, 2022
Quantitating and assessing interoperability between electronic health records
Journal of the American Medical Informatics Association
Bernstam E et al
January 5, 2022
The Chasm between Cancer Quality Measures and EHR Data Quality
JCO Clinical Cancer Informatics
Schorer A et al
February 1, 2021
Impact of Broadening Trial Eligibility Criteria for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients: Real-World Analysis of Select ASCO-Friends Recommendations
Cancer Clinical Research
Harvey D et al
June 1, 2021
Summary of the 12 Most Common Cancers in the CancerLinQ Discovery (CLQD) Database
JCO Clinical Cancer Informatics
Potter D et al
October 2, 2020
Development of CancerLinQ, a health information learning platform from multiple Electronic Health Record (EHR) systems to support improved quality of care
JCO Clinical Cancer Informatics
Potter D et al
Abstracts
February 17, 2023
Real-world treatment patterns and sequencing in patients with locally advanced or metastatic urothelial cancer (la/mUC) in the US
ASCO Genitourinary Cancers Symposium 2023
Kearney M et al
December 12, 2022
Survival of patients with multiple myeloma diagnosed with second primary malignancies: An ASCO CancerLinQ analysis
ASH Annual Meeting & Exposition 2022
Cooper JD et al
December 11, 2022
Secondary primary malignancies (SPMs) in adolescent and young adults (AYAs) with multiple myeloma (MM): An ASCO CancerLinQ analysis
ASH Annual Meeting & Exposition 2022
Gibson SJ et al
December 10, 2022
Racial disparities in newly diagnosed hematological malignancies in the United States during the COVID-19 pandemic, January 2020 to March 2021
ASH Annual Meeting & Exposition 2022
Bhandari S et al
December 6, 2022
Real world treatment patterns of adjuvant endocrine therapy and ovarian suppression in premenopausal HR+/HER2+ breast cancer
San Antonio Breast Conference Symposium 2022
Sukumar JS et al
September 10, 2022
Demographics, clinical characteristics, treatment patterns and clinical outcomes of patients with stages I-III resected NSCLC without known EGFR mutations
European Society for Medical Oncology 2022
Altorki NK et al
August 7, 2022
Long term survival outcomes in NSCLC patients with targeted therapy and immunotherapy: An IASLC analysis of ASCO CancerLinQ Discovery data
World Conference on Lung Cancer 2022
Behera M et al
June 3, 2022
Comparison of DNA sequencing, immunohistochemistry, and in-situ hybridization techniques to determine HER2 status in metastatic breast cancer patients
ASCO Annual Meeting 2022
Lal LS et al
June 3, 2022
Disparities in timely treatment among lung cancer patients
ASCO Annual Meeting 2022
Chhabra J et al
